Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 31 - 40 of 841

Buprenorphine (MOUD) Q&A

This web page provides frequently asked questions for rules on prescribing buprenorphine and other and other medications for opioid use disorder (MOUD), following 2023 policy updates.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
Web Page

Commonly Used Drugs Charts

This NIDA web page includes information on commonly used drugs, including prescription drugs, with the potential for misuse or addiction.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Community Safety Topic - Opioids

This overview of opioids from the NSC includes information on opioid misuse, recognizing signs of an overdose, prescription painkillers and chronic pain, and more.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Policymakers and Payers
First Responders
Source
National Safety Council (NSC)
Year
Resource Type
Web Page

Considerations for Buprenorphine Initiation and Maintenance Care

This virtual public meeting which explored real-world experiences and scientific evidence for buprenorphine initiation strategies, as well as medication dosing and management during continued treatment across different care settings
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Regan-Udall Foundation for the FDA
Year
Resource Type
Video

DAWN 2022 Non-Fatal Overdoses Short Report

This report from the Drug Abuse Warning Network (DAWN) focuses on estimates and characteristics of non-fatal overdoses for emergency department visits from January, 2021–June, 2022.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Policymakers and Payers
Communities
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF

DAWN Findings from Drug-Related Emergency Department Visits, 2022

This report provides national estimates from the Drug Abuse Warning Network (DAWN) for 2022 data on drug-related emergency department visits, to inform programs to aid in preventing overdose and substance use-related health consequences.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Policymakers and Payers
Communities
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF

DEA Announces Important Change to Registration Requirement

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
PDF

Digital Therapeutics (DTx) Product Library

To help key stakeholders understand and differentiate digital therapeutics from the thousands of other mobile health apps that are available, this library highlights evidence-based innovative digital therapeutics products.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Policymakers and Payers
Source
Digital Therapeutics Alliance (DTA)
Year
Resource Type
Web Page